StonvexLoading…
StonvexStonvexStonvexCore line items from JBGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $127.60M | $498.60M | $371.04M | $247.16M |
Operating Income | $-23.04M | $-171.89M | $-111.25M | $-77.16M |
Net Income | $-18.70M | $-139.06M | $-93.52M | $-64.96M |
EPS (Diluted) | $-0.32 | $-2.09 | $-1.35 | $-0.87 |
Total Assets | $4.34B | $4.39B | $4.42B | $4.55B |
Total Liabilities | $2.70B | $2.72B | $2.66B | $2.68B |
Cash & Equivalents | $79.78M | $75.27M | $64.44M | $61.43M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 59.07M | 67.36M | 59.30M | 61.95M |